Why Canopy Growth (TSX:WEED) Stock Could Skyrocket to $100 After Cracking Open Another Cold One With Constellation Brands (NYSE:STZ)

Constellation Brands Inc. (NYSE:STZ) took a bigger puff out of Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on Wednesday. Here’s why there’s more upside on the horizon for Canopy and the rest of Canada’s marijuana stocks.

| More on:

Canopy Growth (TSX:WEED)(NYSE:CGC) stock soared 31% in a single trading session following the announcement that alcohol firm Constellation Brands (NYSE:STZ) has returned to invest another $4 billion in the marijuana giant, bringing its total stake from 9.9% to 38%. The overwhelmingly positive news caused the broader basket of pot stocks to surge by double-digit percentage points with Aphria and Aurora Cannabis stock flying 20.5% and 19.5%, respectively.

Just last month, I’d predicted that Constellation would return for another Canopy stake, which would ultimately result in a complete buyout of the marijuana firm at some point down the road. I thought it was clear that Constellation was just dipping its toe into the marijuana waters with its first 9.9% stake, and that it would be back for larger puff come the next trough in the broader pot market.

Although many analysts have argued that pot stock valuations make “no sense whatsoever,” the big bet made by Constellation is nonetheless another colossal vote of confidence from a highly established firm that’s essentially turned a threat in legal cannabis into an opportunity to revamp sales and gain ground over its peers in the “sin” space. If Constellation is willing to pay up at these levels, retail investors should have no problem, as long as they’re willing to hold onto their position for at least five years.

I think it’s inevitable that the marijuana market will grow to become much larger than that of beer and wine industries. And now that Constellation has a front-row seat with a fatter piece of the pot pie, I think the floodgates are about to open, as institutional investors and other sin companies open their wallets wide to place bigger bets of their own in Canada’s major pot players like Aurora Cannabis, Aphria or Hydropothecary. Think of it as “keeping up with the Joneses.”

The Foolish bottom line

Although Wednesday’s rally was potentially exaggerated thanks to the sudden return of short-term traders, I believe another Santa Claus marijuana rally is in the cards for the latter part of this year and would encourage long-term investors to continue adding to their positions in a cautious manner, much like Constellation has done.

Over the past month, I’ve noted that traders have lost confidence in their short-term trades, leading me to believe that the weakness in the industry was an opportunistic entry point for long-term investors who’d wanted to participate in the marijuana “green rush” without suffering too large of a hangover.

Constellation’s larger investment in Canopy has brought the entire marijuana sector back into the limelight, however, so if you think you’ve missed out after the +31% pop, it was probably my fault for not pounding the table harder on pot stocks, as the as the public grew increasingly pessimistic and impatient.

Although it seems like you missed out, I believe the best has yet to come, so if you’ve got disposable cash on the sidelines, you may want to take a “slow and steady” tortoise approach (as Constellation did) to build your marijuana position before legalization day (or judgement day) finally comes to be.

I think there’s plenty of upside, but please go in with a long-term mindset; otherwise, you’re just going to end up throwing in the towel with a fat loss, causing you to break Warren Buffett’s number one rule: don’t lose money.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Investing

thinking
Dividend Stocks

Should You Buy BCE Stock for its 8.6% Dividend Yield?

Down over 20% from all-time highs, BCE stock offers you a tasty dividend yield in 2024. But is the TSX…

Read more »

grow dividends
Tech Stocks

Why Nuvei Stock Jumped 26% on Monday

Nuvei (TSX:NVEI) stock saw shares surge today as the company confirmed it's in talks to go private through a buyout.

Read more »

consider the options
Investing

Better Buy for the Dividend: Enbridge or Nutrien?

Enbridge (TSX:ENB) and Nutrien (TSX:ENB) are great dividend plays for new investors going into April.

Read more »

Gold bars
Stocks for Beginners

TSX Materials in March 2024: The Best Stock to Buy Right Now

Materials have been quite volatile, though the price of gold has surged to all-time highs. That makes this stock a…

Read more »

grow dividends
Dividend Stocks

How Long Would It Take to Turn $20,000 Into $100,000 With TSX Dividend Stocks?

Here's how high-quality TSX dividend stocks and the power of compound interest can help grow your investments by 400% or…

Read more »

Happy diverse people together in the park
Tech Stocks

A Once-in-a-Generation Investment Opportunity: Artificial Intelligence (AI) Growth Stocks

Canadian tech companies like Kinaxis (TSX:KXS) are doing big things in AI.

Read more »

Paper airplanes flying on blue sky with form of growing graph
Dividend Stocks

2 Soaring Stocks I’d Buy Now With No Hesitation

These two stocks may be the most expensive on the market, but they're high for a reason! And I'm still…

Read more »

Arrowings ascending on a chalkboard
Investing

This Canadian Blue Chip Is Trouncing TSX Returns, and It Still Has Room to Run

Alimentation Couche-Tard (TSX:ATD) stock looks quite frothy heading into earnings, but there may still be upside.

Read more »